• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VAR2CSA特异性免疫球蛋白G的Fc-岩藻糖基化与胎盘恶性疟原虫疟疾的临床免疫

Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.

作者信息

Lopez-Perez Mary, Viwami Firmine, Ampomah Paulina, Šuštić Tonći, Larsen Mads Delbo, Wuhrer Manfred, Vidarsson Gestur, Ofori Michael F, Tuikue Ndam Nicaise, Hviid Lars

机构信息

Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Institut de Recherche Clinique du Benin, Abomey Calavi, Benin.

出版信息

J Infect Dis. 2024 Nov 25. doi: 10.1093/infdis/jiae529.

DOI:10.1093/infdis/jiae529
PMID:39585195
Abstract

BACKGROUND

Acquired immunity to Plasmodium falciparum malaria is mainly mediated by immunoglobulin G (IgG) targeting erythrocyte membrane protein 1 (PfEMP1). These adhesins mediate infected erythrocyte (IE) sequestration, protecting IEs from splenic destruction. PfEMP1-specific IgG is therefore thought to protect mainly by inhibiting IE sequestration. VAR2CSA-type PfEMP1 mediates placental IE sequestration, putting pregnant women exposed to P falciparum parasites at risk of placental malaria (PM).

METHODS

Levels and Fc-afucosylation of VAR2CSA-specific plasma IgG were measured by a modified enzyme-linked immunosorbent assay (FEASI). We also measured the ability of the IgG to inhibit IE adhesion and to induce natural killer (NK) cell degranulation. The results were related to parity and clinical pregnancy outcomes.

RESULTS

Parity was positively correlated with levels and Fc-afucosylation of VAR2CSA-specific IgG, and with birth weight and plasma IgG inhibition of IE adhesion in vitro. Fc-afucosylation of VAR2CSA-specific IgG increased NK-cell degranulation. Women with Fc-afucosylated VAR2CSA-specific IgG had a reduced risk of delivering a low birth weight (LBW) baby, but not of PM or anemia.

CONCLUSIONS

Fc-afucosylated VAR2CSA-specific IgG effectively induced NK-cell degranulation and was associated with protection against LBW, independent of IgG levels. Our study has implications for the development of VAR2CSA-based subunit vaccines, which exclusively induce Fc-fucosylated IgG.

摘要

背景

对恶性疟原虫疟疾的获得性免疫主要由靶向红细胞膜蛋白1(PfEMP1)的免疫球蛋白G(IgG)介导。这些黏附素介导感染红细胞(IE)的滞留,保护IE免受脾脏破坏。因此,PfEMP1特异性IgG被认为主要通过抑制IE滞留来提供保护。VAR2CSA型PfEMP1介导胎盘IE滞留,使暴露于恶性疟原虫寄生虫的孕妇有患胎盘疟疾(PM)的风险。

方法

通过改良酶联免疫吸附测定(FEASI)测量VAR2CSA特异性血浆IgG的水平和Fc-岩藻糖基化。我们还测量了IgG抑制IE黏附以及诱导自然杀伤(NK)细胞脱颗粒的能力。结果与产次和临床妊娠结局相关。

结果

产次与VAR2CSA特异性IgG的水平和Fc-岩藻糖基化呈正相关,与出生体重以及体外血浆IgG对IE黏附的抑制作用呈正相关。VAR2CSA特异性IgG的Fc-岩藻糖基化增加了NK细胞的脱颗粒。具有Fc-岩藻糖基化VAR2CSA特异性IgG的女性分娩低出生体重(LBW)婴儿的风险降低,但患PM或贫血的风险未降低。

结论

Fc-岩藻糖基化的VAR2CSA特异性IgG有效地诱导了NK细胞脱颗粒,并且与预防LBW相关,与IgG水平无关。我们的研究对基于VAR2CSA的亚单位疫苗的开发具有启示意义,该疫苗专门诱导Fc-岩藻糖基化的IgG。

相似文献

1
Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.VAR2CSA特异性免疫球蛋白G的Fc-岩藻糖基化与胎盘恶性疟原虫疟疾的临床免疫
J Infect Dis. 2024 Nov 25. doi: 10.1093/infdis/jiae529.
2
Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.免疫逃避:疟原虫感染红细胞表面 PfEMP1 暴露的保护性 IgG 表位被 IgM 掩盖导致恶性疟原虫疟疾
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12485-90. doi: 10.1073/pnas.1103708108. Epub 2011 Jul 11.
3
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria.疟原虫红细胞膜蛋白1特异性IgG的Fc-岩藻糖基化的获得具有年龄依赖性,并与疟疾的临床保护相关。
Nat Commun. 2025 Jan 2;16(1):237. doi: 10.1038/s41467-024-55543-w.
4
VAR2CSA-Specific IgG Subclass Responses Reflect Protection Against Low Birth Weight and Pregnancy-Associated Malaria.VAR2CSA 特异性 IgG 亚类反应反映了对低出生体重和妊娠相关疟疾的保护作用。
Front Immunol. 2021 Apr 21;12:610305. doi: 10.3389/fimmu.2021.610305. eCollection 2021.
5
IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax.哥伦比亚人群对恶性疟原虫抗原 VAR2CSA 的 IgG 应答仅限于妊娠期间,并且不会因感染间日疟原虫而诱导产生。
Infect Immun. 2018 Jul 23;86(8). doi: 10.1128/IAI.00136-18. Print 2018 Aug.
6
Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination.感染而非亚单位疫苗接种可诱导无岩藻糖基化恶性疟原虫特异性 IgG。
Nat Commun. 2021 Oct 5;12(1):5838. doi: 10.1038/s41467-021-26118-w.
7
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.利用疟原虫 falciparum 胎盘疟疾疫苗候选物 VAR2CSA 诱导功能性 IgG 的差异。
PLoS One. 2011 Mar 25;6(3):e17942. doi: 10.1371/journal.pone.0017942.
8
Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line.对选择用于黏附BeWo胎盘细胞系的缺乏VAR2CSA的恶性疟原虫感染红细胞的特性分析。
Malar J. 2008 Mar 26;7:51. doi: 10.1186/1475-2875-7-51.
9
Antibody mediated activation of natural killer cells in malaria exposed pregnant women.疟疾暴露孕妇体内抗体介导的自然杀伤细胞激活。
Sci Rep. 2021 Feb 18;11(1):4130. doi: 10.1038/s41598-021-83093-4.
10
Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.贝宁:针对胎盘疟疾的保护性抗体与孕期不良结局
Emerg Infect Dis. 2015 May;21(5):813-23. doi: 10.3201/eid2105.141626.

引用本文的文献

1
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria.疟原虫红细胞膜蛋白1特异性IgG的Fc-岩藻糖基化的获得具有年龄依赖性,并与疟疾的临床保护相关。
Nat Commun. 2025 Jan 2;16(1):237. doi: 10.1038/s41467-024-55543-w.

本文引用的文献

1
Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.PfSPZ 疫苗在马里健康成年人和预期怀孕妇女中的安全性和有效性:两项随机、双盲、安慰剂对照、1 期和 2 期试验。
Lancet Infect Dis. 2024 Dec;24(12):1366-1382. doi: 10.1016/S1473-3099(24)00360-8. Epub 2024 Aug 14.
2
PfEMP1 and var genes - Still of key importance in Plasmodium falciparum malaria pathogenesis and immunity.PfEMP1 和 var 基因——在恶性疟原虫致病机制和免疫中仍然具有关键重要性。
Adv Parasitol. 2024;125:53-103. doi: 10.1016/bs.apar.2024.02.001. Epub 2024 Mar 23.
3
GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout.
GlYcoLISA:基于免疫吸附测定和 LC-MS 读数的抗原特异性和亚类特异性 IgG Fc 糖基化分析。
Nat Protoc. 2024 Jun;19(6):1887-1909. doi: 10.1038/s41596-024-00963-7. Epub 2024 Feb 21.
4
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.疟疾疫苗候选物 R21/Matrix-M 在非洲儿童中的安全性和有效性:一项多中心、双盲、随机、3 期临床试验。
Lancet. 2024 Feb 10;403(10426):533-544. doi: 10.1016/S0140-6736(23)02511-4. Epub 2024 Feb 1.
5
Assessment of IgG-Fc glycosylation from individual RhD-specific B cell clones reveals regulation at clonal rather than clonotypic level.对单个RhD特异性B细胞克隆的IgG-Fc糖基化评估揭示了在克隆水平而非克隆型水平上的调控。
Immunology. 2024 Mar;171(3):428-439. doi: 10.1111/imm.13737. Epub 2023 Dec 14.
6
Seasonal vaccination with RTS,S/AS01 vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial.在布基纳法索和马里,5 岁以下儿童接种 RTS,S/AS01 季节性疫苗结合或不结合季节性疟疾化学预防:一项双盲、随机、对照、3 期临床试验。
Lancet Infect Dis. 2024 Jan;24(1):75-86. doi: 10.1016/S1473-3099(23)00368-7. Epub 2023 Aug 22.
7
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?胎盘疟疾疫苗抗原 VAR2CSA 的构象表位:它能给我们什么启示?
PLoS Pathog. 2023 May 25;19(5):e1011370. doi: 10.1371/journal.ppat.1011370. eCollection 2023 May.
8
Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria.疟疾驱动的适应性样功能 CD56- NK 细胞的扩张与疟疾的临床免疫相关。
Sci Transl Med. 2023 Jan 25;15(680):eadd9012. doi: 10.1126/scitranslmed.add9012.
9
Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.在马里使用抗疟疾单克隆抗体的安全性和有效性。
N Engl J Med. 2022 Nov 17;387(20):1833-1842. doi: 10.1056/NEJMoa2206966. Epub 2022 Oct 31.
10
Immunomagnetic Selection of Plasmodium falciparum-Infected Erythrocytes Expressing Particular PfEMP1 Variants.免疫磁珠筛选表达特定 PfEMP1 变异体的恶性疟原虫感染红细胞。
Methods Mol Biol. 2022;2470:69-78. doi: 10.1007/978-1-0716-2189-9_7.